Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
09 Agosto 2024 - 5:36PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Schedule 14A
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934
| | | | | | | | | | | |
| ☒ | Filed by the Registrant | ☐ | Filed by a Party other than the Registrant |
| | | | | |
| Check the appropriate box: |
| ☐ | Preliminary Proxy Statement |
| ☐ | CONFIDENTIAL, FOR USE OF THE COMMISSION ONLY (AS PERMITTED BY RULE 14a-6(e)(2)) |
| ☐ | Definitive Proxy Statement |
| ☒ | Definitive Additional Materials |
| ☐ | Soliciting Material Pursuant to §240.14a-12 |
®Medtronic plc
(Exact name of Registrant as specified in its charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
| | | | | |
| Payment of Filing Fee (Check the appropriate box): |
| ☒ | No fee required. |
| ☐ | Fee paid previously with preliminary materials. |
| ☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 |
Medtronic (NYSE:MDT)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024
Medtronic (NYSE:MDT)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024
